首页> 外文OA文献 >LEADER 2:baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

【2h】

LEADER 2:baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

机译：领先者2：基线降钙素在9340名2型糖尿病患者中参与了利拉鲁肽的作用和对糖尿病的作用：评估心血管结局结果（LEADER）试验：初步观察

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Daniels, G H; Hegedüs, L; Marso, S P; Nauck, M A; Zinman, B; Bergenstal, R M; Mann, J F E; Derving Karsbøl, J; Moses, A C; Buse, J B; Tuttle, R M; LEADER trial investigators;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations [J] . Daniels G. H., Hegedus L., Marso S. P., Diabetes, obesity & metabolism . 2015,第5期

机译：领导者2：9340名2型糖尿病患者的降钙素基线水平参与了利拉鲁肽的治疗作用和作用：评估心血管结局结果（LEADER）试验：初步观察
2. Do Some Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1 RA) Reduce Macrovascular Complications of Type 2 Diabetes Mellitus? A Commentary on the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) Trial [J] . Athyros Vasilios G., Katsiki Niki, Tentolouris Nikolaos Current vascular pharmacology . 2016,第5期

机译：某些胰高血糖素样肽1受体激动剂（GLP-1 RA）是否能减少2型糖尿病的大血管并发症？利拉鲁肽在糖尿病中的作用和作用的评述：心血管结果评估（LEADER）试验
3. Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial [J] . Crowley Matthew J., McGuire Darren K., Alexopoulos Anastasia-Stefania, Diabetes care . 2020,第9期

机译：Liraglutide对2型糖尿病患者心血管结果的影响，无基线二甲双胍使用：领导者试验后HOC分析
4. Rationale, Design and Preliminary Results of ROMEO (Rethink Organization to Improve Education and Outcomes) A Randomized Controlled Multicenter Trial of Group Care in the Management ofType 1 Diabetes [C] . M. Porta, M. Trent European Association for the Study of Diabetes . 2005

机译：Romeo（重新思考组织改善教育和结果）的基本理由，设计和初步结果，在1型糖尿病的术语中进行了随机对照的组织的多中心试验
5. Barriers to physical activity in people with type 2 diabetes mellitus enrolled in a worksite disease management program [D] . Erickson, Deborah L. 2008

机译：参加工作场所疾病管理计划的2型糖尿病患者的身体活动障碍
6. LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations [O] . G H Daniels, L Hegedüs, S P Marso, -1

机译：领导者2：9340名2型糖尿病患者的降钙素基线水平参与了利拉鲁肽的治疗作用和作用：评估心血管结局结果（LEADER）试验：初步观察
7. Follow the LEADER—Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial [O] . 2016

机译：遵循领导者—来拉鲁肽在糖尿病中的作用和作用：评估心血管结果的试验

LEADER 2:baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

著录项

相似文献

相关主题

期刊订阅